IFF stock holds near consensus targets as earnings miss reshapes expectations

International Flavors & Fragrances Inc. (IFF, ISIN US4595061015) stock is trading a little above $83 as of August 21, 2026, with recent market data showing an opening price of $81.97 and a last quoted level of $83.40 on the New York Stock Exchange.

Per recent market coverage on August 21, 2026, the shares stood at $83.40, only marginally above the prior close of $83.39, underscoring a relatively steady short-term trading range for investors watching the name.

At the same time, the company’s latest quarterly results, reported on August 4, 2026, delivered earnings per share of $0.82 and revenue of $1.95 billion, missing consensus expectations of $1.07 in EPS and $2.62 billion in revenue for the period.

This combination of a muted share move and a clear earnings shortfall has sharpened attention on how IFF balances its growth ambitions with profitability and capital allocation decisions across its core fragrance, flavor, and ingredients portfolio.

Earnings miss and margin profile

According to detailed earnings summaries dated August 21, 2026, IFF’s most recent quarter showed EPS of $0.82, falling short of the $1.07 analyst consensus and reflecting a $0.25 gap between reported profits and market expectations for the period.

The same report notes that quarterly revenue reached $1.95 billion, versus forecasts of $2.62 billion, highlighting a shortfall of $670 million against analyst projections and pointing to softer demand or mix within key segments.

Despite the miss, revenue still grew 1.8 percent year over year, as the company modestly expanded its top line compared with the $1.92 billion level recorded in the equivalent quarter a year earlier, when EPS had come in at $1.15.

Net margin for the latest quarter was reported at 2.78 percent and return on equity at 7.11 percent, illustrating a business that remains profitable but operates with relatively thin margins given the scale of its $1.95 billion quarterly sales base.

For investors, the contrast between modest revenue growth and a declining EPS figure versus last year’s $1.15 per share underscores the importance of ongoing cost discipline and pricing strategy as management seeks to defend margins in an inflation-sensitive consumer and industrial demand environment.

Consensus, valuation and capital returns

Fresh analyst consensus data compiled on August 22, 2026 shows an average twelve-month price target of $92.16 for IFF stock, based on research from 20 Wall Street equity analysts covering the name over the past year.

With the shares recently quoted around $84.19 in this same consensus overview, the $92.16 target implies a forecasted upside of 9.46 percent from that $84.19 reference price, indicating that analysts still expect moderate appreciation despite the latest earnings miss.

The consensus range spans a high target of $105.00 and a low target of $71.00, suggesting divided views on how strongly IFF can expand margins and earnings in the medium term and how much investors should pay for that potential.

Recent market commentary from August 21, 2026 indicates that IFF has authorized a substantial share-repurchase program with a size of $2.5 billion, giving management flexibility to return capital to shareholders or offset dilution from equity-based compensation over time.

In the same coverage, the overall analyst stance on the stock is described as a “Moderate Buy” consensus, even as some research houses have moved to more cautious ratings and reduced their earnings estimates, reflecting a blend of confidence in the long-term franchise and concern over near-term profitability.

For the current fiscal year, equities analysts as a group expect IFF to deliver $3.08 in EPS, according to these compilations, which sets a baseline against which investors can judge whether future quarters are closing the gap to expectations or deepening the shortfall.

Estimate cuts and earnings trajectory

Detailed estimate revisions published on August 21, 2026 show that one prominent research provider has reduced multi-year earnings forecasts for IFF, lowering projected EPS for fiscal 2026 to $3.14 from a previous view of $4.45.

The same revisions cut the 2027 EPS estimate to $3.71 from $4.81 and the 2028 EPS forecast to $4.31 from $5.21, marking sizable reductions of $1.31, $1.10, and $0.90, respectively, compared with the prior expectations for those years.

Quarterly projections have also come down, with the estimate for Q3 2026 EPS now at $0.67 versus an earlier expectation of $1.14, reducing the forecast by $0.47 and suggesting weaker profitability in the near term.

These downward revisions align with concerns that the recent earnings miss, margin compression, and revenue shortfall could persist across several reporting periods, especially if input costs remain elevated or if volumes in key fragrance and flavor categories soften.

For valuation, the combination of a share price in the low-$80s, consensus EPS expectations around the low-$3 range, and thin net margins points to a scenario where investors may demand clear evidence of operational improvements before paying up for the higher end of the $71 to $105 price-target range.

Nonetheless, the existence of a $2.5 billion buyback authorization and a still-positive consensus target suggests that the market sees room for earnings recovery, provided that management delivers on cost savings, integration benefits, and product innovation across the portfolio.

IFF’s product portfolio and applications

IFF’s core business centers on creating fragrance and flavor solutions used in consumer products such as perfumes, household cleaners, packaged foods, beverages, and personal care items, as well as specialty ingredients for health and nutrition applications.

Its solutions underpin many branded goods in supermarkets and pharmacies, where consistent scent, taste, and performance are critical to customer loyalty and price realization for consumer-goods makers.

Beyond traditional fragrance and flavor compounds, the company also supplies functional ingredients and taste-modulation technologies that help customers reformulate products for sugar reduction, salt reduction, or enhanced mouthfeel without sacrificing consumer acceptance.

In addition, IFF has expanded into natural and biotechnology-derived ingredients, using fermentation and advanced science to produce flavors, enzymes, and other components that meet demand for clean-label and sustainable formulations.

From an investor perspective, this broad product base gives IFF exposure to long-term trends in health, wellness, and premiumization, but the recent earnings miss shows that translating those demand drivers into consistent margin expansion is not automatic.

Closing market snapshot

Recent NYSE trading data as of August 21, 2026 shows IFF stock quoted at $83.40, with the session’s opening level at $81.97 and only a $0.01 gain versus the prior close, signaling a relatively tight daily trading range.

Against an average twelve-month analyst price target of $92.16 compiled by consensus sources on August 22, 2026, the current zone in the low-$80s leaves moderate upside potential if the company can improve profitability and deliver on its earnings trajectory toward the expected $3.08 EPS for the year.

For now, investors in IFF are weighing a modest revenue growth profile, thin margins, and reduced earnings estimates against the support of a sizable $2.5 billion share-repurchase authorization and a consensus that still leans toward a constructive stance on the stock.

Fact box

Company: International Flavors & Fragrances Inc.

ISIN: US4595061015

Ticker: IFF

Exchange: NYSE

Price (as of August 21, 2026, 1:29 a.m. ET): $83.40 USD

Sector / Industry: Materials / Specialty chemicals

Index membership: S&P 500